Palabras clave
Mortalidad
Epidemiología
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar la tendencia temporal de las tasas de mortalidad por cáncer de próstata en Brasil y sus regiones geográficas entre los años 2000 y 2020. Métodos: Se analizaron los números de muertes por neoplasias malignas de próstata (CIE-10: C61) obtenidas de la página oficial del Ministerio de Salud de Brasil, así como datos de la población residente. El patrón temporal y geográfico se analizó utilizando la tasa de mortalidad estandarizada por edad y se evaluó en un modelo de regresión utilizando puntos de inflexión. Resultados: En Brasil, la tasa de mortalidad analizada se mantuvo estable (AAPC: 0,1; IC95: -0,5-0,7). El estudio de las regiones brasileñas mostró un crecimiento promedio del índice en las regiones Nordeste (AAPC: 3,7; IC95: 3,1-4,2) y Norte (AAPC: 2,1; IC95:1,1-3,1), frente a la disminución observada en el Sur (AAPC: -1,4; IC95: -2,5--0,2), Sudeste (AAPC: -1,3; IC95: -2,2--0,4) y Centro-Oeste (AAPC: -0,8; IC95: -1,3--0,2). Conclusión: La mortalidad por cáncer de próstata en Brasil se mantuvo constante entre 2000 y 2020, con incrementos en el Nordeste y Norte, y disminuciones en el Sur, Sudeste y Centro-Oeste. Estas variaciones regionales subrayan la importancia de estrategias de salud adaptadas a las necesidades específicas de cada región.
Referencias
ALLOTT E, et al. Obesity and Prostate Cancer: Weighing the Evidence. European Urology, 2013; 63: 5.
ARRUDA GO, et al. Prevalence and factors associated with the use of public health services for adult men. Ciência & Saúde Coletiva, 2017, 22: 1.
BARBER L, et al. Family History of Breast or Prostate Cancer and Prostate Cancer Risk. Clinical Cancer Research, 2018; 24: 23.
BARBOSA BB, et al. Food and Nutrition Surveillance System (SISVAN) coverage, nutritional status of older adults and its relationship with social inequalities in Brazil, 2008-2019: an ecological time-series study. Epidemiologia e Serviços de Saúde, 2023, 32: 1.
BELON AP, et al. Mortality among adults: gender and socioeconomic differences in a Brazilian city. BMC Public Health, 2012; 12: 1.
BRAGA SF, et al. Time trends for prostate cancer mortality in Brazil and its geographic regions: An age–period–cohort analysis. Cancer Epidemiology, 2017; 50.
BRASIL. Ministério da Saúde. Departamento de Informática do Sistema Único de Saúde (DATASUS), 2022. Disponível https ://datasus.saude.gov.br/informacoes-de-saude-tabnet. Acesso em: 10 nov 2022.
CARTER HB, et al. Early Detection of Prostate Cancer: AUA Guideline. Journal of Urology, 2013; 190: 2.
CHAN JM, et al. Role of Diet in Prostate Cancer Development and Progression. Journal of Clinical Oncology, 2005; 23: 32.
CHIN HW, et al. Prostate Cancer in Seniors: Part 1: Epidemiology, Pathology, and Screening. Federal practitioner: for the health care professionals of the VA, DoD, and PHS, 2015; 32(4).
CONCEIÇÃO MBM, et al. Time trends in prostate cancer mortality according to major geographic regions of Brazil: an analysis of three decades. Cadernos de Saúde Pública, 2014; 30: 3.
CZORNY RCN, et al. Fatores de risco para o câncer de próstata: população de uma unidade básica de saúde. Cogitare Enfermagem, 2017; 22: 4.
HEGDE JV, et al. Multiparametric MRI of prostate cancer: An update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. Journal of Magnetic Resonance Imaging, 2013; 37: 5.
HOUGHTON N, et al. Socioeconomic inequalities in access barriers to seeking health services in four Latin American countries. Revista Panamericana de Salud Pública, 2020; 44: e11.
HU X, et al. Role of Adiponectin in prostate cancer. International Brazilian Journal of Urology, 2019; 45: 2.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA (IBGE). Censo Demográfico 2022. Rio de Janeiro: IBGE, 2022.
INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA (INCA). Estimativa 2023: incidência do Câncer no Brasil. Rio de Janeiro: INCA, 2022.
ISER DA, et al. Prostate cancer mortality in Brazil 1990-2019: geographical distribution and trends. Revista Brasileira de Medicina Tropical, 2022, 55: 1.
JEREZ-ROIG J, et al. Future burden of prostate cancer mortality in Brazil: a population-based study. Cadernos de Saúde Pública, 2014; 30: 11.
KLEIN J, VON DEM KNESEBECK O. Socioeconomic inequalities in prostate cancer survival: A review of the evidence and explanatory factors. Social Science & Medicine, 2015; 142.
LITWIN MS, TAN H. The Diagnosis and Treatment of Prostate Cancer: A Review. JAMA: The Journal of the American Medical Association, 2017; 317: 24.
MOURA EC, et al. Perceptions about men’s health in gender relational perspective, Brazil, 2014. Ciência & Saúde Coletiva, 2017; 22: 1.
MOURÃO TC, et al. Epidemiology of Urological Cancers in Brazil: Trends in Mortality Rates Over More Than Two Decades. Journal of Epidemiology and Global Health, 2022; 12: 3.
NICLIS C, et al. Traditional Dietary Pattern Increases Risk of Prostate Cancer in Argentina: Results of a Multilevel Modeling and Bias Analysis from a Case-Control Study. Journal of Cancer Epidemiology, 2015; 2015.
PALLER CJ, et al. Racial Inequality in Prostate Cancer Outcomes - Socioeconomics, Not Biology. JAMA Oncology, 2019; 5: 7.
RAWLA P. Epidemiology of Prostate Cancer. World Journal of Oncology, 2019; 10: 2.
RIBEIRO AA, NARDOCCI AC. Desigualdades socioeconômicas na incidência e mortalidade por câncer: revisão de estudos ecológicos, 1998-2008. Saúde e Sociedade, 2013; 22: 3.
RIBEIRO AG, et al. Cancer inequalities in incidence and mortality in the State of São Paulo, Brazil 2001-17. Cancer Medicine, 2023; 12: 15.
ROMERO FR, et al. The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and meta-analysis. International Brazilian Journal of Urology, 2012; 38: 4.
SANTOS EFS, et al. Social inequalities in access to cancer screening and early detection: A population-based study in the city of São Paulo, Brazil. Clinics, 2023; 78: 100160.
SCHRÖDER FH. et al. Screening and Prostate-Cancer Mortality in a Randomized European Study. New England Journal of medicine, 2019; 360: 13.
SIERRA MS, et al. Prostate cancer burden in Central and South America. Cancer Epidemiology, 2016; 44.
SOUZA R, et al. Perfil sociodemográfico e clínico de pacientes atendidos em um serviço ambulatorial de quimioterapia paliativa em Belo Horizonte. Revista Mineira de Enfermagem, 2012; 16: 1.
STEELE CB, et al. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study. Cancer, 2017; 123.
SUNG H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a Cancer Journal for Clinicians, 2021; 71: 3.
TOURINHO-BARBOSA RR, et al. Prostate cancer in Brazil and Latin America: epidemiology and screening. International Brazilian Journal of Urology, 2016; 42: 6.
TREWARTHA D, CARTER K. Advances in prostate cancer treatment. Nature Reviews Drug Discovery, 2013; 12: 11.
WOLF AMD, et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA: A Cancer Journal for Clinicians, 2010; 60: 2.